Dr. Mylonakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Ste 1001
Houston, TX 77030Phone+1 617-670-9115Fax+1 713-790-2797
Education & Training
University of AthensClass of 1990
Certifications & Licensure
TX State Medical License 2023 - 2026
RI State Medical License 2012 - 2024
MA State Medical License 2002 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsnTZDpa (non-thiazolidinedione PPARγ partial agonist) derivatives retain antimicrobial activity without improving renal toxicity.Madeline M Dekarske, Lewis Oscar Felix, Carlos Monteagudo Ortiz, Erika E Csatary, Elefterios Mylonakis
Bioorganic & Medicinal Chemistry Letters. 2022-05-15 - SARS-CoV-2 Variants and Their Clinical Significance: An Update as of May 2022.Eleftherios Mylonakis
Rhode Island Medical Journal. 2022-08-01 - Cumulative incidence and mortality rate of cardiovascular complications due to laboratory-confirmed influenza virus infection: A systematic review and meta-analysis.Konstantinos Ouranos, Stephanos Vassilopoulos, Athanasios Vassilopoulos, Fadi Shehadeh, Eleftherios Mylonakis
Reviews in Medical Virology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
